ACRIVON THERAPEUTICS INC (ACRV) Stock Cash Flow
NASDAQ:ACRV - Nasdaq - US0048901096 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -76.98M | -60.39M | -31.17M | -16.24M | -5.31M | |||
| Depreciation Amortization | 849.00K | 536.00K | 360.00K | 40.00K | 10.00K | |||
| Change In Working Capital | 4.49M | 8.14M | -1.53M | 330.00K | 320.00K | |||
| Other non cash items | 10.96M | 9.07M | 2.22M | 1.90M | 2.17M | |||
| OPERATING CASH FLOW | -60.67M | -42.64M | -30.12M | -13.98M | -2.80M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -3.09M | -1.29M | -2.17M | -240.00K | -20.00K | |||
| Other Investing Activity | -42.56M | 52.01M | -139.51M | N/A | N/A | |||
| INVESTING CASH FLOW | -45.65M | 50.72M | -141.68M | -240.00K | -20.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | 0.00 | 60.00K | |||
| Stock Issued/Repurchased | 122.83M | -257.00K | 1.90M | 112.22M | 2.83M | |||
| Other Financing Activity | -3.17M | -1.30M | 99.81M | N/A | N/A | |||
| FINANCING CASH FLOW | 119.66M | -1.55M | 101.71M | 112.22M | 2.89M | |||
| CHANGE IN CASH | 13.34M | 6.52M | -70.09M | 98.00M | 70.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -60.67M | -42.64M | -30.12M | -13.98M | -2.80M | |||
| Capital Expenditure | -3.09M | -1.29M | -2.17M | -240.00K | -20.00K | |||
| FREE CASH FLOW | -63.76M | -43.93M | -32.29M | -14.22M | -2.82M | |||
All data in USD